| MMay 15 2013 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 22,000 | Option exercise at $36.33 | $799,198 |
| MMay 15 2013 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 12,000 | Sale at $67.90 | $814,784 |
| May 15 2013 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 37,800 | Grant at $0.00 | $0 |
| May 14 2013 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 15,000 | Option exercise at $12.99 | $194,850 |
| May 14 2013 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 15,000 | Sale at $70.17 | $1,052,492 |
| MMay 14 2013 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 25,000 | Option exercise at $12.99 | $324,750 |
| MMay 14 2013 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 25,000 | Sale at $70.94 | $1,773,551 |
| MMay 10 2013 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 15,800 | Sale at $68.77 | $1,086,601 |
| May 12 2013 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 8,873 | Option payment at $67.68 | $600,525 |
| MMay 13 2013 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 14,128 | Gift at $0.00 | $0 |
| MMay 13 2013 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 8,000 | Option exercise at $12.99 | $103,920 |
| May 7 2013 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 3,000 | Option exercise at $12.99 | $38,970 |
| MMay 7 2013 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 4,000 | Sale at $65.87 | $263,492 |
| May 8 2013 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 5,479 | Option payment at $65.32 | $357,888 |
| May 8 2013 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 1,000 | Gift at $0.00 | $0 |
| MMay 3 2013 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 8,000 | Option exercise at $12.99 | $103,920 |
| MMay 3 2013 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 8,000 | Sale at $67.24 | $537,950 |
| Apr 30 2013 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 916 | Grant at $23.20 | $21,256 |
| MApr 30 2013 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 3,000 | Sale at $64.99 | $194,982 |
| May 2 2013 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 2,000 | Option exercise at $12.99 | $25,980 |
| Mar 26 2013 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 12,000 | Option exercise at $12.99 | $155,880 |
| Mar 26 2013 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 12,000 | Sale at $60.68 | $728,147 |
| MFeb 28 2013 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 10,000 | Option exercise at $12.99 | $129,900 |
| MFeb 28 2013 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 11,000 | Sale at $59.01 | $649,140 |
| Feb 27 2013 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 1,500 | Sale at $56.46 | $84,683 |
| Feb 4 2013 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 2,000 | Option exercise at $12.99 | $25,980 |
| Feb 4 2013 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 2,000 | Sale at $55.77 | $111,532 |
| MJan 22 2013 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 14,000 | Sale at $55.06 | $770,880 |
| Jan 18 2013 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 5,000 | Option exercise at $12.99 | $64,950 |
| Jan 18 2013 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 5,000 | Sale at $54.00 | $270,000 |
| Jan 4 2013 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 3,000 | Option exercise at $12.99 | $38,970 |
| Jan 4 2013 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 3,000 | Sale at $52.24 | $156,731 |
| Dec 31 2012 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 5,000 | Option exercise at $12.99 | $64,950 |
| Dec 31 2012 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 5,000 | Sale at $48.62 | $243,116 |
| MDec 24 2012 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 17,000 | Option exercise at $12.99 | $220,830 |
| MDec 24 2012 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 17,000 | Sale at $48.37 | $822,244 |
| MDec 21 2012 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 9,000 | Option exercise at $12.99 | $116,910 |
| MDec 21 2012 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 9,000 | Sale at $48.57 | $437,137 |
| Dec 12 2012 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 5,000 | Option exercise at $12.99 | $64,950 |
| Dec 12 2012 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 5,000 | Sale at $50.00 | $250,000 |
| MDec 7 2012 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 6,000 | Option exercise at $11.43 | $68,550 |
| MDec 7 2012 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 6,000 | Sale at $47.53 | $285,207 |
| Dec 4 2012 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 5,000 | Option exercise at $12.99 | $64,950 |
| Dec 4 2012 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 5,000 | Sale at $47.94 | $239,692 |
| Nov 16 2012 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 8,000 | Option exercise at $12.99 | $103,920 |
| Nov 16 2012 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 8,000 | Sale at $48.05 | $384,366 |
| Nov 14 2012 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 4,000 | Option exercise at $12.99 | $51,960 |
| Nov 14 2012 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 4,000 | Sale at $48.50 | $193,987 |
| MNov 7 2012 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 7,000 | Sale at $47.62 | $333,314 |
| Oct 31 2012 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 3,000 | Option exercise at $9.86 | $29,580 |
| MOct 31 2012 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 4,000 | Sale at $37.96 | $151,856 |
| Oct 22 2012 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 3,000 | Option exercise at $9.86 | $29,580 |
| Oct 22 2012 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 3,000 | Sale at $41.86 | $125,579 |
| Oct 19 2012 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 2,000 | Sale at $42.72 | $85,440 |
| Oct 12 2012 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 3,000 | Option exercise at $9.86 | $29,580 |
| Oct 12 2012 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 3,000 | Sale at $41.32 | $123,969 |
| Sep 28 2012 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 4,000 | Option exercise at $9.86 | $39,440 |
| Sep 28 2012 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 4,000 | Sale at $40.20 | $160,804 |
| Sep 14 2012 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 4,000 | Option exercise at $9.86 | $39,440 |
| Sep 14 2012 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 4,000 | Sale at $37.91 | $151,628 |
| Sep 10 2012 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 1,000 | Sale at $38.62 | $38,620 |
| Jun 4 2012 | ITMN | Intermune Inc | Bienaime Jean Jacques | Director | 2,500 | Grant at $10.10 | $25,250 |
| May 31 2012 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 2,000 | Option exercise at $6.46 | $12,920 |
| May 31 2012 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 8,000 | Option exercise at $6.46 | $51,680 |
| MMay 16 2012 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 15,000 | Option exercise at $9.86 | $147,900 |
| MMay 16 2012 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 15,000 | Sale at $38.49 | $577,370 |
| MMay 11 2012 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 40,000 | Option exercise at $9.01 | $360,400 |
| MMay 11 2012 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 40,500 | Sale at $38.06 | $1,541,549 |
| May 8 2012 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 56,000 | Grant at $0.00 | $0 |
| MMay 7 2012 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 20,000 | Option exercise at $9.86 | $197,200 |
| MMay 7 2012 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 20,000 | Sale at $36.38 | $727,600 |
| MMay 3 2012 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 20,000 | Option exercise at $9.86 | $197,200 |
| MMay 3 2012 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 20,000 | Sale at $36.34 | $726,800 |
| Apr 30 2012 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 1,098 | Grant at $19.35 | $21,242 |
| MMay 1 2012 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 30,000 | Option exercise at $9.86 | $295,800 |
| MMay 1 2012 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 30,000 | Sale at $35.24 | $1,057,120 |
| Apr 27 2012 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 20,000 | Option exercise at $9.86 | $197,200 |
| MApr 27 2012 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 22,000 | Sale at $34.99 | $769,872 |
| MApr 6 2012 | ITMN | Intermune Inc | Bienaime Jean Jacques | Director | 4,225 | Grant at $0.00 | $0 |
| Mar 9 2012 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 15,000 | Option exercise at $6.47 | $97,050 |
| Mar 9 2012 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 15,000 | Sale at $34.46 | $516,867 |
| Mar 8 2012 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 1,000 | Sale at $35.00 | $35,000 |
| Feb 29 2012 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 1,000 | Sale at $36.26 | $36,258 |
| MFeb 24 2012 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 5,000 | Sale at $35.64 | $178,209 |
| Feb 23 2012 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 5,000 | Sale at $35.31 | $176,541 |
| Sep 28 2011 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 1,000 | Sale at $32.00 | $32,000 |
| Aug 30 2011 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 2,000 | Option exercise at $6.46 | $12,920 |
| Aug 30 2011 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 2,000 | Sale at $29.01 | $58,018 |
| Aug 19 2011 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 2,000 | Option exercise at $6.46 | $12,920 |
| Aug 19 2011 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 2,000 | Sale at $26.75 | $53,496 |
| Aug 12 2011 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 3,000 | Option exercise at $6.46 | $19,380 |
| Aug 12 2011 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 3,000 | Sale at $27.10 | $81,288 |
| Aug 2 2011 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 4,000 | Option exercise at $6.46 | $25,840 |
| MAug 2 2011 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 8,000 | Sale at $30.27 | $242,136 |
| Jul 26 2011 | NGSX | Neurogesx Inc | Bienaime Jean Jacques | Director | 11,627 | Grant at $1.65 | $19,185 |
| Jul 14 2011 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 1,000 | Sale at $30.00 | $30,000 |
| Jun 6 2011 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 2,000 | Sale at $27.39 | $54,772 |
| Jun 7 2011 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 5,000 | Option exercise at $0.00 | $0 |
| May 31 2011 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 710 | Sale at $28.00 | $19,880 |
| May 27 2011 | BMRN | Biomarin Pharmaceutical Inc | Bienaime Jean Jacques | CEO | 290 | Sale at $28.00 | $8,120 |
